1. A Multicenter Phase II Study of Gemcitabine, Capecitabine, and Bevacizumab for Locally Advanced or Metastatic Biliary Tract Cancer. (July 2018) Authors: Iyer, Renuka V.; Pokuri, Venkata K.; Groman, Adrienne; Ma, Wen W.; Malhotra, Usha; Iancu, Dan M.; Grande, Catherine; Saab, Tanios B. Journal: American journal of clinical oncology Issue: Volume 41:Number 7(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗